CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines robust fundamentals with a promising chart pattern, making it worth a closer look.
Fundamental Strengths
High Growth: CPRX has demonstrated strong earnings growth, with EPS increasing by 112% over the past year. Revenue growth has also been solid at 23.5% annually.
Profitability: The company boasts an operating margin of 39.7%, outperforming 99% of its biotechnology peers. Return on equity stands at 22.5%, reflecting efficient capital use.
Financial Health: With no debt and a current ratio of 5.2, CPRX maintains a strong balance sheet. Its Altman-Z score of 17.1 indicates low bankruptcy risk.
Attractive Valuation: Trading at a P/E of 15.7, CPRX appears undervalued compared to both its industry and the broader market.
Technical Setup
Positive Trends: Both short-term and long-term trends are bullish, with the stock trading near the upper end of its 52-week range.
Support Levels: Multiple support zones exist between $23.28 and $21.40, providing a cushion against downside risk.
Breakout Potential: Resistance sits at $24.84. A move above this level could signal further upside.
Volume & Momentum: The stock has shown consistent buying interest, with above-average liquidity supporting price action.
This is not investing advice! The article highlights observations at the time of writing, but you should always conduct your own analysis before making investment decisions.